SOFINICLINE (ABT-894 ) FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
3- (5, 6-Dichloro-pyridin-3-yl) -IS, 5S-3, 6-diazabicyclo [3.2.0] heptane (SOFINICLINE, ABT-894) and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-def icit/hyperactivity disorder.
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
10.12.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | 3- (5, 6-Dichloro-pyridin-3-yl) -IS, 5S-3, 6-diazabicyclo [3.2.0] heptane (SOFINICLINE, ABT-894) and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-def icit/hyperactivity disorder. |
---|---|
AbstractList | 3- (5, 6-Dichloro-pyridin-3-yl) -IS, 5S-3, 6-diazabicyclo [3.2.0] heptane (SOFINICLINE, ABT-894) and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-def icit/hyperactivity disorder. |
Author | ABI-SAAB, WALID M DUTTA, SANDEEP AWNI, WALID M GARIMELLA, TUSHAR S SALTARELLI, MARIO D BAIN, EARLE E |
Author_xml | – fullname: BAIN, EARLE E – fullname: AWNI, WALID M – fullname: GARIMELLA, TUSHAR S – fullname: ABI-SAAB, WALID M – fullname: SALTARELLI, MARIO D – fullname: DUTTA, SANDEEP |
BookMark | eNrjYmDJy89L5WRwDvZ38_TzdPbx9HNV0HB0CtG1sDRR0FRw8w9ScAwJcfUL8fT303VxdfN09gzR94gMcA1ydA7xDPMMiVRw8Qz2D3JxDeJhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjkbmRqYm5gaOhsZEKAEAusEscw |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | SOFINICLINE (ABT-894) POUR DES TROUBLES DE DEFICIT DE L'ATTENTION/HYPERACTIVITE |
ExternalDocumentID | CA2725470A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA2725470A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:57:45 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA2725470A13 |
Notes | Application Number: CA20092725470 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091210&DB=EPODOC&CC=CA&NR=2725470A1 |
ParticipantIDs | epo_espacenet_CA2725470A1 |
PublicationCentury | 2000 |
PublicationDate | 20091210 |
PublicationDateYYYYMMDD | 2009-12-10 |
PublicationDate_xml | – month: 12 year: 2009 text: 20091210 day: 10 |
PublicationDecade | 2000 |
PublicationYear | 2009 |
RelatedCompanies | ABBOTT LABORATORIES |
RelatedCompanies_xml | – name: ABBOTT LABORATORIES |
Score | 2.760323 |
Snippet | 3- (5, 6-Dichloro-pyridin-3-yl) -IS, 5S-3, 6-diazabicyclo [3.2.0] heptane (SOFINICLINE, ABT-894) and salts thereof are effective nicotinic receptor agonist... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | SOFINICLINE (ABT-894 ) FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091210&DB=EPODOC&locale=&CC=CA&NR=2725470A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOqbokbwI30wiz4ssC_GHhYzui7UyCBQCTyRdYyEl0Fkxn_f6wLoi741bXK5Nrne_a73uwI8Lhyp6FNLvYPoBwFK29SltDw9NRCyoL_3DKlSA_243Xu3X6fOtAKrPRem7BP6VTZHRItK0d6L8r7e_CSxwrK2ctuUK5xav0TCD7U9OvZUPywt7PpsOAgHVKPUp4EWj3zTRSTktgIESkcYRbuq-otNuoqUsvntUaJzOB6isLy4gEqW1-CU7j9eq8FJf_fejcOd6W0vgY4HEY85feMxI09BV-gdzybPBFEcCYRgsco16SGLOOWi2ZsN2UgViEy4mJGQjxHrsdEVkIgJ2tNRm_lh53MaHPS2rqGar_PsBsgy6ViJnaboWtp2opi01kKaGFdkrpFlTqsO9T_FNP5Zu4Uzc_c7gtG6g2rx8Zndo8st5EN5WN8pmn3Q |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QNeJNUSM-92AaPTTQB9AeGlO223QVCoGVwImwpSRcCpEa_76zDaAXvW12k8nMJrMz3-w8AB7nDanKpxa6g-gHAUrT1KW0XD0xELKgvXcNqUID3bgZvduv48a4BMtdLUzRJ_SraI6IGpWgvufFe73-CWIFRW7lpiaXuLV6CYUXaDt07Kp-WFrQ9li_F_SoRqlHfS0eeGYLkVCr7iNQOkQP21Ft9tmorYpS1r8tSngKR30kluVnUEqzCpTpbvBaBY672_9uXG5Vb3MOdNgLecxph8eMPPltoTuuTZ4JojjiC8FiFWvSAxZyykUtmvTZQCWIjLiYkIAPEeuxwQWQkAka6cjNdC_5lPp7vq1LOMhWWXoFZDFzrJmdJGhamvZMVdJac2miX5G2jDRt1KtQ_ZPM9T9nD1CORLczRUHebuDE3E5KMOq3cJB_fKZ3aH5zeV9c3Dc4JIDA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SOFINICLINE+%28ABT-894+%29+FOR+ATTENTION-DEFICIT%2FHYPERACTIVITY+DISORDER&rft.inventor=BAIN%2C+EARLE+E&rft.inventor=AWNI%2C+WALID+M&rft.inventor=GARIMELLA%2C+TUSHAR+S&rft.inventor=ABI-SAAB%2C+WALID+M&rft.inventor=SALTARELLI%2C+MARIO+D&rft.inventor=DUTTA%2C+SANDEEP&rft.date=2009-12-10&rft.externalDBID=A1&rft.externalDocID=CA2725470A1 |